North China Pharmaceutical Company Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 5,583.088 million compared to CNY 5,917.328 million a year ago. Operating income was CNY 48.836 million compared to CNY 158.018 million a year ago. Net income was CNY 1.005 million compared to CNY 120.022 million a year ago. Basic earnings per share from continuing operations was CNY 0.001 compared to CNY 0.074 a year ago.